{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:26:50Z","timestamp":1737437210297,"version":"3.33.0"},"reference-count":0,"publisher":"Pasifika Medical Association Group","issue":"1608","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NZMJ"],"abstract":"<jats:p>aim: There are limited data on the prevalence of calcific aortic valve disease (CAVD) in M\u0101ori and known inequities in outcomes after\naortic valve intervention. Our study aimed to investigate the prevalence of CAVD in M\u0101ori.\nmethods: Data from initial clinically indicated echocardiograms performed between 2010 to 2018 in patients aged \u226518 years were\nlinked to nationally collected outcome data. Ethnicity was defined using protocols from the Ministry of Health.\nresults: Of the 23,635 patients, 1,312 (5.6%) identified as M\u0101ori, and 22,323 (94.4%) as European. Prevalence of aortic stenosis was\n5.3% in M\u0101ori and 9.9% in Europeans. Age-specific prevalence did not differ between the two groups. M\u0101ori with CAVD were more than\ntwice as likely to have advanced cardiac impairment (right ventricular dysfunction) than Europeans (10.1% vs 4.6, p&lt;0.001).\nconclusions: Age-specific CAVD rates did not differ between M\u0101ori and Europeans, though M\u0101ori had a higher proportion of advanced\ncardiac impairment, which is likely unrelated to CAVD. Differences in population structure likely explain the difference in overall\nprevalence of CAVD. The improving life expectancy in M\u0101ori may lead to increasing incidence of CAVD, thus strategies to improve\ndetection and medical management of CAVD should begin as soon as possible.<\/jats:p>","DOI":"10.26635\/6965.6621","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T22:38:21Z","timestamp":1737412701000},"page":"84-93","source":"Crossref","is-referenced-by-count":0,"title":["The prevalence of aortic stenosis in M\u0101ori undergoing clinically indicated echocardiography compared to New Zealand Europeans"],"prefix":"10.26635","volume":"138","author":[{"given":"Matthew","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11177","published-online":{"date-parts":[[2025,1,24]]},"container-title":["New Zealand Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T22:38:26Z","timestamp":1737412706000},"score":1,"resource":{"primary":{"URL":"https:\/\/nzmj.org.nz\/journal\/vol-138-no-1608\/the-prevalence-of-aortic-stenosis-in-maori-undergoing-clinically-indicated-echocardiography-compared-to-new-zealand-europeans"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":0,"journal-issue":{"issue":"1608","published-online":{"date-parts":[[2025,1,24]]}},"URL":"https:\/\/doi.org\/10.26635\/6965.6621","relation":{},"ISSN":["1175-8716"],"issn-type":[{"value":"1175-8716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}